日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma

赖氨酸去甲基化酶KDM4C是致癌驱动因子,并在KRAS突变型胰腺导管腺癌中调节ERK活性。

Menna-T-Allah Shaheen,Sarah Dhebat,Kimal I Rajapakshe,Bidyut Ghosh,Benson Chellakkan Selvanesan,Shariq S Ansari,Cara L Haymaker,Dorsay Sadeghian,Huamin Wang,Ching-Fei Li,Haoqiang Ying,Anirban Maitra

KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer

KRAS抑制激活胰腺癌中可发挥作用的CD24“别吃我”信号

Yongkun Wei ,Minghui Liu # ,Er-Yen Yen # ,Jun Yao # ,Zhenzhen Xun ,Phuoc T Nguyen ,Xiaofei Wang ,Zecheng Yang ,Abdelrahman Yousef ,Dean Pan ,Yanqing Jin ,Ching-Fei Li ,Madelaine S Theardy ,Jangho Park ,Yiming Cai ,Mitsunobu Takeda ,Matthew Vasquez ,Elizabeth M Park ,David H Peng ,Yong Zhou ,Hong Zhao ,Timothy P Heffernan ,Andrea Viale ,Huamin Wang ,Stephanie S Watowich ,Han Liang ,Dan Zhao ,Ronald A DePinho ,Wantong Yao ,Haoqiang Ying

Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer

Nardilysin 调节的断裂机制激活 polo 样激酶 3 以抑制胰腺癌的发展

Jie Fu #, Jianhua Ling #, Ching-Fei Li, Chi-Lin Tsai, Wenjuan Yin, Junwei Hou, Ping Chen, Yu Cao, Ya'an Kang, Yichen Sun, Xianghou Xia, Zhou Jiang, Kenei Furukawa, Yu Lu, Min Wu, Qian Huang, Jun Yao, David H Hawke, Bih-Fang Pan, Jun Zhao, Jiaxing Huang, Huamin Wang, E I Mustapha Bahassi, Peter J Sta

Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex

靶向 ALK-CDK9-Tyr19 激酶级联可通过破坏 P-TEFb 复合物的稳定性,增强卵巢和乳腺肿瘤对 PARP 抑制的敏感性

Yu-Yi Chu, Mei-Kuang Chen, Yongkun Wei, Heng-Huan Lee, Weiya Xia, Ying-Nai Wang, Clinton Yam, Jennifer L Hsu, Hung-Ling Wang, Wei-Chao Chang, Hirohito Yamaguchi, Zhou Jiang, Chunxiao Liu, Ching-Fei Li, Lei Nie, Li-Chuan Chan, Yuan Gao, Shao-Chun Wang, Jinsong Liu, Shannon N Westin, Sanghoon Lee, Ani

Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death

开发和表征可保护T细胞免受半乳糖凝集素-9诱导的细胞死亡的抗半乳糖凝集素-9抗体

Riyao Yang ,Linlin Sun ,Ching-Fei Li ,Yu-Han Wang ,Weiya Xia ,Boning Liu ,Yu-Yi Chu ,Laura Bover ,Long Vien ,Mien-Chie Hung

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

半乳糖凝集素-9与PD-1和TIM-3相互作用,调节T细胞死亡,是癌症免疫治疗的靶点。

Riyao Yang # ,Linlin Sun # ,Ching-Fei Li ,Yu-Han Wang ,Jun Yao ,Hui Li ,Meisi Yan ,Wei-Chao Chang ,Jung-Mao Hsu ,Jong-Ho Cha ,Jennifer L Hsu ,Cheng-Wei Chou ,Xian Sun ,Yalan Deng ,Chao-Kai Chou ,Dihua Yu ,Mien-Chie Hung